Application

13980180 · USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

Filed 2013-10-14 · Granted · Patent 10222377 (2019-03-05) The official file ↗The patent and its PDF ↗ · Art unit 1615 · Examiner Shirley V Gembeh Easy · CPC G01N 33/57484 · DEUTSCHES KREBSFORSCHUNGSZENTRUM · FBT Gibbons LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

4.8 mo

to disposition 64.7 mo

Statutes raised

101 103 112

6 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.